Voderdeucitinib
Voderdeucitinib (Compoudn I) is a TYK2 inhibitor with an anti-inflammatory activity. Voderdeucitinib can be used for inflammatory and autoimmune disease research, such as rheumatoid arthritis (RA), multiple sclerosis and intestinal bowel disease (IBD) [1].
Product Specifications
CAS Number
[2824164-00-1]
UNSPSC
12352005
Target
JAK
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(C1=C(NC2=CC=CC3=C2N(C)CC4=CN(C)N=C43)C=C(NC(C5CC5)=O)N=C1)NC([2H])([2H])[2H]
Molecular Formula
C23H22D3N7O2
Molecular Weight
434.51
References & Citations
[1]Anjali P, et al. Tyk2 inhibitors and uses thereof. WO2024042363A1. 2025-03-20.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-175310S/
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
Tyk2
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Dock11 shRNA (UAS) - Lentiviral mouse Dock11 shRNA (UAS, RFP) (100)
Phospho-CHEK2 (Thr26) Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
